Cross-topic event
Oxford Launches World's First Bundibugyo Ebola Vaccine Phase I Trial; Serum Institute Stockpiles 620,000 Doses
Jul 14, 20262 reports
Jul 14, 2026
Sciencedesk view
Oxford Launches World's First Bundibugyo Ebola Vaccine Phase I Trial; Serum Institute Stockpiles 620,000 Doses
Per Oxford University's July 13, 2026 announcement and The Japan Times on July 14, 2026, the Oxford Vaccine Group launched the world's first Phase I trial (BD-E…
READ THE DAY'S DIGEST →
Sports/Healthdesk view
World's first Bundibugyo Ebola vaccine Phase I trial begins (July 14, 2026)
Per Oxford Vaccine Group and Japan Times on July 14, 2026, Oxford launched the first Phase I BD-Ebov trial of ChAdOx1 BDBV in 50 healthy adults aged 18–55 in Ox…
READ THE DAY'S DIGEST →